Skip to main content

Closed

FATE: Fate Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-2207.5%

ROIC-53.8%

Financially safe

Stretched

Debt / equity0.43×

Interest coverage0.0×

Current ratio5.85×

Fate Therapeutics, Inc.

FATENASDAQ Global Market·USD·Closed

Fate Therapeutics, Inc.

FATENASDAQ·USD·Closed

$2.45

−2.39%

$2.45

−$0.06 (2.39%)

52W Range

66thpctl

Volume

0.22×avg

Mkt Cap

285.57MUSD

P/E

-2.2TTM

Div Yield

–ann

52W Range

66thpctl

Volume

0.22×avg

Market Cap

285.57MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings